We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

57 hedge funds and large institutions have $11.4M invested in Q32 Bio in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 1.71% → 1.8% (+0.09%)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

2% less funds holding

Funds holding: 58 → 57 (-1)

45% less capital invested

Capital invested by funds: $20.8M → $11.4M (-$9.38M)

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

Holders
57
Holders Change
-1
Holders Change %
-1.72%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
11
Closed
10
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
-$54K

Top Buyers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
+$1.14M
2
BCM
BML Capital Management
Indiana
+$608K
3
GKFF
George Kaiser Family Foundation
Oklahoma
+$217K
4
XT
XTX Topco
Cayman Islands
+$27.5K
5
VF
Virtu Financial
New York
+$27.4K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$658K
2
WSL
Western Standard LLC
California
-$293K
3
BCM
Bridgeway Capital Management
Texas
-$217K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$138K
5
Bank of America
Bank of America
North Carolina
-$94.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$3.44M – – –
5VM
2
5AM Venture Management
California
$2.76M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.18M -$86.8K -5,936 -5%
NM
4
Newtyn Management
New York
$851K +$1.14M +77,737 New
BlackRock
5
BlackRock
New York
$663K -$13.1K -898 -1%
BCM
6
BML Capital Management
Indiana
$455K +$608K +41,562 New
EAM
7
Erste Asset Management
Austria
$328K – – –
VC
8
Vivo Capital
California
$225K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$197K – – –
GKFF
10
George Kaiser Family Foundation
Oklahoma
$186K +$217K +14,845 +680%
ACM
11
ADAR1 Capital Management
Texas
$179K +$239K +16,315 New
Bank of America
12
Bank of America
North Carolina
$115K -$94.3K -6,450 -38%
Renaissance Technologies
13
Renaissance Technologies
New York
$106K -$4.39K -300 -3%
State Street
14
State Street
Massachusetts
$81.4K – – –
Tudor Investment Corp
15
Tudor Investment Corp
Connecticut
$70.3K – – –
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$60.2K -$13.2K -906 -14%
Citadel Advisors
17
Citadel Advisors
Florida
$42.1K -$658K -44,996 -92%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$40.3K +$2.28K +156 +4%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$40K -$51.6K -3,530 -49%
Northern Trust
20
Northern Trust
Illinois
$40K – – –
DIM
21
DLK Investment Management
California
$36.5K +$48.7K +3,333 New
RC
22
RBF Capital
California
$35.7K – – –
XT
23
XTX Topco
Cayman Islands
$33.5K +$27.5K +1,882 +160%
Barclays
24
Barclays
United Kingdom
$32.6K – – –
Franklin Resources
25
Franklin Resources
California
$24.9K – – –
1
2 3

QTTB Hedge Fund Activity: Q4 2023 in Review

57 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2023, worth a combined $11.4M — down 45% from $20.8M a quarter earlier.

Fund positioning in QTTB was balanced in Q4 2023: 10 funds opened new positions, 10 closed out, 6 added to existing stakes and 11 trimmed.

The largest buyer was Newtyn Management, opening a new position worth an estimated $1.14M. The largest seller was Citadel Advisors, cutting an estimated $658K.

  • 57 institutional investors held Q32 Bio (QTTB) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $11.4M of Q32 Bio stock for Q4 2023, down 45% quarter-over-quarter.
  • 10 funds opened new Q32 Bio positions in Q4 2023 and 10 closed out, a net change of 0 holders.
  • The largest Q32 Bio buyer in Q4 2023 was Newtyn Management, an estimated $1.14M added.
  • The largest Q32 Bio seller in Q4 2023 was Citadel Advisors, an estimated $658K sold.

Based on aggregated 13F filings for Q4 2023.